Ivim semaglutide is a compounded GLP-1 sold through a telehealth membership. Compare pricing, dosing, side effects, and FDA rules with brand-name options.
Ivim semaglutide refers to the compounded GLP-1 weight loss medication prescribed through Ivim Health, a US telehealth membership program. Ivim does not manufacture drugs; it connects patients with licensed providers and partner compounding pharmacies that dispense the medication. That distinction matters because compounded semaglutide is not FDA-approved, and it is not the same product as brand-name Ozempic or Wegovy.
What Ivim Semaglutide Actually Is
Ivim Health is a direct-to-consumer telehealth platform focused on weight loss, hormone therapy, and primary care. Its weight loss track centers on GLP-1 medications, including compounded semaglutide and compounded tirzepatide, along with provider check-ins and optional coaching.
Compounded semaglutide is a custom-prepared version of the same active molecule found in Ozempic and Wegovy. When people look up semaglutide ingredients, they are usually trying to confirm one thing: that the vial contains real semaglutide rather than a vitamin blend or an unregulated "research chemical."
- Active ingredient: semaglutide, the same GLP-1 receptor agonist used in brand-name products.
- Format: usually a multi-dose vial with syringes, or a prefilled pen, injected once weekly.
- Source: a state-licensed compounding pharmacy, not the original brand manufacturer.
- Program extras: provider consultations, dose adjustments, and nutrition support.
Compounded semaglutide is not FDA-approved for human use in the United States. It is legal only under specific compounding rules, and the regulatory picture tightened considerably after the FDA declared the semaglutide shortage resolved in early 2025.
How Much Does Ivim Semaglutide Cost?
Ivim's pricing is membership-based, meaning the medication and the program are usually bundled into one monthly fee. Plans generally start in the low hundreds of dollars per month and rise as the dose increases. Exact prices change often, so confirm current numbers with the company before signing up.
| Option | Typical monthly cost | Format | Insurance |
|---|---|---|---|
| Ivim compounded semaglutide | Roughly $200–$400 | Vial plus syringes, weekly injection | Usually not accepted |
| Wegovy (brand, weight loss) | $1,300+ without insurance | Single-dose pen | Often covered with prior authorization |
| Ozempic (brand, type 2 diabetes) | $900–$1,000+ without insurance | Single-dose pen | Covered for diabetes, rarely for weight loss |
| Other compounded semaglutide | $100–$500 | Vial or pen | Not accepted |
Cash-pay telehealth programs exist largely because insurance coverage for weight loss GLP-1s remains inconsistent. Even where coverage exists, many plans require a BMI threshold, a related diagnosis, or proof of a prior weight loss attempt.
Dosing: Why the Dose Goes Up Over Time
Semaglutide is started low and increased slowly so the body can adapt. A standard escalation runs 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg per week. The starting doses are not intended to drive weight loss; they are tolerance-building steps.
There is also a practical reason why increase dose of semaglutide for weight loss is such a common question. GLP-1 receptors respond less strongly with continuous exposure, so a dose that produced steady appetite suppression in month two may feel weaker by month five. Providers raise the dose to restore the effect, not because the medication stopped working entirely.
Moving up faster than the schedule does not produce faster results. It mainly produces more nausea, more fatigue, and a higher chance of quitting altogether.
Side Effects and Safety
Gastrointestinal effects dominate the side effect profile: nausea, vomiting, diarrhea, constipation, burping, and abdominal discomfort. Most of these are mild to moderate and ease within a few weeks of starting or increasing a dose.
Does everyone have side effects from semaglutide? No. Plenty of people report almost none, while others find the GI effects genuinely hard to tolerate. In clinical trials, a meaningful share of participants stopped treatment because of digestive symptoms.
Two concerns come up constantly in patient communities. Can semaglutide cause hair loss? Possibly, and the likely mechanism is rapid weight loss plus reduced nutrient intake rather than the drug damaging hair follicles directly. Semaglutide and alcohol can also be a rough combination, which is why many clinicians advise limiting drinking, especially during dose increases, since alcohol adds nausea and dehydration on top of the drug's effects.
Rare but serious risks include pancreatitis, gallbladder disease, and bowel obstruction. Semaglutide also carries a boxed warning about thyroid C-cell tumors observed in rodents, and it is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN2.
Where Ivim Fits in the Semaglutide Market
Ivim competes with a crowded field of telehealth weight loss programs, including offerings tied to established commercial brands such as Weight Watchers. The main differentiators are price, whether provider visits are included, and how quickly a prescription ships.
If you are trying to figure out where to buy semaglutide, the safest answer is a licensed US pharmacy with a valid prescription from a clinician who reviews your health history. Vials sold through social media, peptide sites, or overseas sellers carry real risk of contamination, wrong concentration, or no active ingredient at all.
A telehealth membership is not a substitute for ongoing medical care. Anyone with diabetes, kidney disease, a history of pancreatitis, or who is pregnant or breastfeeding should talk with a physician before starting any GLP-1 medication.
Frequently Asked Questions
Is Ivim semaglutide the same as Ozempic or Wegovy?
No. Ivim prescribes compounded semaglutide prepared by a licensed compounding pharmacy, while Ozempic and Wegovy are FDA-approved brand products made by Novo Nordisk. They share the same active ingredient, but the formulations, dosing devices, and regulatory status are different.
Is compounded semaglutide still legal after the FDA shortage ended?
The FDA declared the semaglutide shortage resolved in early 2025, which sharply curtailed large-scale compounding of the drug. Some state-licensed pharmacies can still prepare it under narrow exceptions, but the rules are shifting and vary by state. Ask the dispensing pharmacy for its current licensing and sourcing details.
What are the most common side effects of Ivim semaglutide?
Nausea, constipation, diarrhea, vomiting, and fatigue are the most frequently reported effects, and they usually ease after a few weeks at a given dose. Serious complications such as pancreatitis and gallbladder disease are rare but possible. Report severe or persistent symptoms to your prescribing provider right away.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.